跳至主要内容
临床试验/PACTR201210000441277
PACTR201210000441277招募中未知

Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial

1. London School of Hygiene and Tropical Medicine (United Kingdom)0 个研究点目标入组 10,000 人开始时间: 2012年10月24日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
10,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 Year(s) 至 150 Year(s)(—)
性别
All

入选标准

  • 2. Traumatic brain injury
  • 3. Within 8 hours of injury
  • 4. Any intracranial bleeding on CT scan OR a GCS of 12 or less
  • 5. No significant extra-cranial haemorrhage
  • 6. Where the responsible clinician is substantially uncertain as to the appropriateness of antifibrinolytic agents in the patient

排除标准

  • The fundamental eligibility criterion is the responsible clinician's 'uncertainty' as to whether or not to use an antifibrinolytic agent in a particular patient with traumatic brain injury

研究者

发起方
1. London School of Hygiene and Tropical Medicine (United Kingdom)

相似试验